We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.26B
AUM Growth
-$105M
Cap. Flow
-$52.6M
Cap. Flow %
-4.16%
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$51.8M
2
BEKE icon
KE Holdings
BEKE
+$31M
3
TSM icon
TSMC
TSM
+$10.9M
4
BZ icon
Kanzhun
BZ
+$6.35M
5
IQ icon
iQIYI
IQ
+$4.37M

Top Sells

Rank Stock Value
1
TME icon
Tencent Music
TME
+$39.2M
2
TCOM icon
Trip.com Group
TCOM
+$19.3M
3
MRVL icon
Marvell Technology
MRVL
+$12M
4
WB icon
Weibo
WB
+$7.99M
5
JOYY
JOYY Inc
JOYY
+$7.61M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.28%
2 Technology 32.43%
3 Communication Services 9.6%
4 Healthcare 8.37%
5 Real Estate 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCID icon
301
Lucid Motors
LCID
$2.46B
$97K 0.01%
1,410
-220
-13% -$15.7K
PNT
302
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$95K 0.01%
+10,524
New +$92.8K
ALLK
303
DELISTED
Allakos
ALLK
$83K 0.01%
18,996
-2,454
-11% -$11K
VNDA icon
304
Vanda Pharmaceuticals
VNDA
$312M
$78K 0.01%
11,832
-1,228
-9% -$7.87K
BTAI icon
305
BioXcel Therapeutics
BTAI
$26.2M
$71K 0.01%
+664
New +$221K
EQRX
306
DELISTED
EQRx, Inc. Common Stock
EQRX
$62K ﹤0.01%
33,322
-29,258
-47% -$52.3K
MRSN
307
DELISTED
Mersana Therapeutics
MRSN
$60K ﹤0.01%
724
-379
-34% -$55.4K
LYEL icon
308
Lyell Immunopharma
LYEL
$309M
$56K ﹤0.01%
875
-562
-39% -$31.1K
KYNB
309
Kyntra Bio
KYNB
$28.5M
$53K ﹤0.01%
781
+223
+40% +$92.2K
ALEC icon
310
Alector
ALEC
$164M
-14,089
Closed -$87K
ALT icon
311
Altimmune
ALT
$539M
-29,334
Closed -$124K
ATRA icon
312
Atara Biotherapeutics
ATRA
$71.2M
-1,282
Closed -$93K
CHRS icon
313
Coherus Oncology
CHRS
$217M
-22,741
Closed -$156K
CRBU icon
314
Caribou Biosciences
CRBU
$156M
-13,274
Closed -$70K
CRDO icon
315
Credo Technology Group
CRDO
$39.7B
-29,479
Closed -$278K
DADA
316
DELISTED
Dada Nexus
DADA
-131,591
Closed -$1.11M
DE icon
317
Deere & Co
DE
$170B
-504
Closed -$208K
FISV
318
Fiserv Inc
FISV
$27.2B
-6,778
Closed -$766K
FSLR icon
319
First Solar
FSLR
$21.8B
-1,071
Closed -$233K
GDX icon
320
VanEck Gold Miners ETF
GDX
$23B
-87,434
Closed -$2.83M
GLD icon
321
SPDR Gold Trust
GLD
$131B
-14,210
Closed -$2.6M
GLDM icon
322
SPDR Gold MiniShares Trust
GLDM
$27.5B
-88,235
Closed -$3.45M
GS icon
323
Goldman Sachs
GS
$313B
-631
Closed -$206K
HUM icon
324
Humana
HUM
$46.7B
-435
Closed -$211K
IAU icon
325
iShares Gold Trust
IAU
$63B
-92,405
Closed -$3.45M

Similar funds

E Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, E Fund Management held 343 positions worth $1.26B, down 7.7% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management withdrew a net $52.6M in Q2 2023, closing 34 positions and reducing 233 holdings. Its most notable exit was Trip.com Group, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 36% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Datadog worth $881K.

  • E Fund Management's largest Q2 2023 buy was Datadog: 8,960 shares worth $881K.
  • E Fund Management added most to Pinduoduo in Q2 2023, an estimated $51.8M increase.
  • E Fund Management's biggest Q2 2023 reduction was Tencent Music, cutting an estimated $39.2M.
  • E Fund Management fully exited Trip.com Group in Q2 2023, selling an estimated $19.3M.
  • E Fund Management's ten largest holdings make up 61% of its $1.26B portfolio in Q2 2023.
  • E Fund Management opened 11 new positions and closed 34 in Q2 2023.
  • E Fund Management's portfolio value fell 7.7% quarter-over-quarter to $1.26B.

Based on E Fund Management's 13F filing for Q2 2023, filed 11 Aug 2023.